Cencora (NYSE:COR) Issues FY 2026 Earnings Guidance

Cencora (NYSE:COR) issued an update on its FY 2026 earnings guidance on Thursday morning. The company provided EPS guidance of 17.700-17.900 for the period, compared to the consensus estimate of 17.760. The company issued revenue guidance of -.

Cencora Stock Up 0.0%

Cencora stock opened at $286.97 on Friday. The company has a current ratio of 0.95, a quick ratio of 0.59 and a debt-to-equity ratio of 3.40. The stock has a market capitalization of $55.83 billion, a price-to-earnings ratio of 22.01, a PEG ratio of 1.59 and a beta of 0.59. Cencora has a twelve month low of $244.82 and a twelve month high of $377.54. The stock has a 50 day moving average of $280.84 and a two-hundred day moving average of $322.18.

Cencora (NYSE:COR) last released its quarterly earnings data on Wednesday, May 6th. The company reported $4.75 EPS for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). The company had revenue of $78.36 billion for the quarter, compared to analysts’ expectations of $81.09 billion. Cencora had a return on equity of 135.20% and a net margin of 0.78%.The firm’s quarterly revenue was up 3.9% on a year-over-year basis. During the same period in the prior year, the firm posted $4.42 EPS. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. As a group, research analysts expect that Cencora will post 17.79 earnings per share for the current year.

Cencora Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, June 1st. Investors of record on Friday, May 15th were given a dividend of $0.60 per share. The ex-dividend date of this dividend was Friday, May 15th. This represents a $2.40 annualized dividend and a yield of 0.8%. Cencora’s dividend payout ratio is 18.40%.

Cencora announced that its board has approved a share repurchase program on Thursday, May 21st that permits the company to buyback $2.00 billion in shares. This buyback authorization permits the company to purchase up to 3.9% of its stock through open market purchases. Stock buyback programs are generally an indication that the company’s leadership believes its stock is undervalued.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on COR shares. Robert W. Baird lowered their price target on Cencora from $420.00 to $339.00 and set an “outperform” rating for the company in a report on Thursday, May 7th. Evercore set a $360.00 price target on Cencora in a research note on Wednesday, April 8th. Barclays decreased their price target on shares of Cencora from $425.00 to $350.00 and set an “overweight” rating for the company in a research report on Wednesday, June 10th. Weiss Ratings downgraded Cencora from a “buy (b)” rating to a “buy (b-)” rating in a research note on Friday, May 22nd. Finally, UBS Group upped their price target on Cencora from $410.00 to $412.00 and gave the company a “buy” rating in a research report on Thursday, May 7th. Twelve equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, Cencora presently has an average rating of “Moderate Buy” and an average target price of $367.75.

Insider Activity at Cencora

In other Cencora news, Director Lauren M. Tyler acquired 550 shares of Cencora stock in a transaction dated Monday, June 22nd. The stock was bought at an average price of $270.23 per share, for a total transaction of $148,626.50. Following the transaction, the director owned 4,359 shares in the company, valued at approximately $1,177,932.57. This trade represents a 14.44% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 0.38% of the company’s stock.

Institutional Investors Weigh In On Cencora

Several institutional investors have recently made changes to their positions in COR. State of Wyoming increased its stake in shares of Cencora by 44.2% during the 2nd quarter. State of Wyoming now owns 1,070 shares of the company’s stock worth $321,000 after purchasing an additional 328 shares during the last quarter. VestGen Advisors LLC increased its position in Cencora by 21.7% during the fourth quarter. VestGen Advisors LLC now owns 902 shares of the company’s stock worth $305,000 after buying an additional 161 shares during the last quarter. Eisler Capital Management Ltd. bought a new position in Cencora during the third quarter valued at about $299,000. BTG Pactual Asset Management US LLC acquired a new stake in shares of Cencora in the fourth quarter worth about $280,000. Finally, Stirlingshire Investments Inc. acquired a new position in shares of Cencora during the 4th quarter valued at about $276,000. 97.52% of the stock is currently owned by institutional investors and hedge funds.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.